ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
59
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,444
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Colony-stimulating factors for febrile neutropenia during cancer therapy.
Author(s):
K C L B Bennett
,
J Armitage
,
B. Norris
,
Benjamin Djulbegovic
Publication date:
2013-03-21
Journal:
The New England journal of medicine
Keywords:
Antineoplastic Combined Chemotherapy Protocols
,
adverse effects
,
Female
,
Granulocyte Colony-Stimulating Factor
,
therapeutic use
,
Humans
,
Lymphoma, Large B-Cell, Diffuse
,
drug therapy
,
Middle Aged
,
Neoplasms
,
complications
,
Neutropenia
,
chemically induced
,
prevention & control
,
Practice Guidelines as Topic
,
Recombinant Proteins
Read this article at
ScienceOpen
Publisher
PMC
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Photoluminescent Nanomaterials
Author and article information
Journal
PubMed ID::
23514290
PMC ID::
3947590
DOI::
10.1056/NEJMct1210890
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Combined Chemotherapy Protocols
,
adverse effects
,
Female
,
Granulocyte Colony-Stimulating Factor
,
therapeutic use
,
Humans
,
Lymphoma, Large B-Cell, Diffuse
,
drug therapy
,
Middle Aged
,
Neoplasms
,
complications
,
Neutropenia
,
chemically induced
,
prevention & control
,
Practice Guidelines as Topic
,
Recombinant Proteins
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Combined Chemotherapy Protocols
,
adverse effects
,
Female
,
Granulocyte Colony-Stimulating Factor
,
therapeutic use
,
Humans
,
Lymphoma, Large B-Cell, Diffuse
,
drug therapy
,
Middle Aged
,
Neoplasms
,
complications
,
Neutropenia
,
chemically induced
,
prevention & control
,
Practice Guidelines as Topic
,
Recombinant Proteins
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,444
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.
Authors:
J. Kelley Bentley
,
H Gurney
,
Michael D. Crowther
…
Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia.
Authors:
AKIHIDE OHKUCHI
,
MITSUAKI SUZUKI
,
TOMOYUKI KUWATA
…
Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes.
Authors:
E Wilde
,
Yu Lu
,
S Lewin
…
See all similar
Cited by
59
Tumor Microenvironment and Differential Responses to Therapy
Authors:
Erik Sahai
,
Eishu Hirata
Cancer-associated stroke: Pathophysiology, detection and management (Review)
Authors:
Efthimios Dardiotis
,
Athina-Maria Aloizou
,
Sofia Markoula
…
Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation
Authors:
Carsten Krieg
,
Daniela Impellizzieri
,
Robert W. Thompson
…
See all cited by